Results 31 to 40 of about 8,790,513 (336)

Cost-effectiveness of Dapagliflozin for the Treatment of Heart Failure With Reduced Ejection Fraction

JAMA Network Open, 2021
Key Points Question Is the addition of dapagliflozin to guideline-directed medical therapy cost-effective for the treatment of heart failure with reduced ejection fraction?
Nicolas Isaza, P. Calvachi, Inbar Raber, Chia-Liang Liu, B. Bellows, Inmaculada Hernandez, Chang-Yu Shen, Michael Gavin, A. Garan, Dhruv S. Kazi   +9 more
semanticscholar   +1 more source

Results of Monte Carlo simulations depicted in incremental-cost-effectiveness-ratio (ICER) planes and cost-effectiveness-acceptability curves (CEAC).

, 2020
Results of Monte Carlo simulations depicted in incremental-cost-effectiveness-ratio (ICER) planes and cost-effectiveness-acceptability curves (CEAC).
Benjamin Birkner (8212203), Jürgen Rech (3741517), Tom Stargardt (5064095)   +2 more
core   +1 more source

Incremental cost-effectiveness ratio by GetCheckedOnline uptake and time horizon.

, 2023
Abbreviations: GCO–GetCheckedOnline; ICER—Incremental cost-effectiveness ratio; QALY—quality-adjusted-life years; WTP—Willingness-to-pay.
Devon Haag (17458212), Wei Zhang (405), Michael A. Irvine (8582391), Jose A. De Anda (17458209), Travis Salway (6088043), Mark Gilbert (286354)   +5 more
core   +1 more source

Cost-Effectiveness of Canagliflozin Versus Dapagliflozin Added to Metformin in Patients With Type 2 Diabetes in China

Frontiers in Pharmacology, 2019
PurposeAgents that inhibit sodium glucose co-transporter 2 (SGLT2), including canagliflozin and dapagliflozin, become available for the treatment of Chinese patients with type 2 diabetes mellitus (T2DM).
Xingyun Hou, Xu Wan, Bin Wu
doaj   +1 more source

Incremental cost effectiveness ratio for patient mortality (percentage) from a healthcare perspective.

, 2023
Incremental cost effectiveness ratio for patient mortality (percentage) from a healthcare perspective.
Sarah Foster (102634), Karin Thursky (4329955), Natasha K. Brusco (6562550), Tammy Dinh (3195393), Douglas Travis (15674709), Kelly Sykes (15674703), Natalie Sullivan (15674712), Camilla Radia-George (15674706), Allen C. Cheng (7326008)   +8 more
core   +1 more source

A Bayesian approach to stochastic cost-effectiveness analysis [PDF]

, 2001
The aim of this paper is to discuss the use of Bayesian methods in cost-effectiveness analysis (CEA) and the common ground between Bayesian and traditional frequentist approaches.
Briggs, A.
core   +5 more sources

Cost-Effectiveness of Secukinumab Versus Other Biologics in the Treatment of Moderate-to-Severe Plaque Psoriasis: The Chinese Healthcare System Perspective

Dermatology and Therapy, 2023
Introduction This study assessed the cost-effectiveness of secukinumab compared with other biologics (adalimumab, infliximab, ustekinumab, ixekizumab, guselkumab, and Yisaipu [etanercept biosimilar]) for moderate-to-severe plaque psoriasis from the ...
Jinsui Zhang, Zemin Xia, Wanjie Guo, Xiaoxiao Ren, Fang Liu, Gargi Ratnaparkhi, Amit Pagada, Subhashini Subramanian, Min Hu, Wen Chen   +9 more
doaj   +1 more source

A Health Opportunity Cost Threshold for Cost-Effectiveness Analysis in the United States

Annals of Internal Medicine, 2020
BACKGROUND Cost-effectiveness analysis is an important tool for informing treatment coverage and pricing decisions, yet no consensus exists about what threshold for the incremental cost-effectiveness ratio (ICER) in dollars per quality-adjusted life-year
D. Vanness, J. Lomas, Hannah Ahn
semanticscholar   +1 more source

Cost-utility analysis: Incremental cost-effectiveness ratio (ICER)—base case.

, 2019
Cost-utility analysis: Incremental cost-effectiveness ratio (ICER)—base case.
Frauke Becker (2836922), Denise Howel (16468), Catherine Haighton (2157001), Martin White (16466), Andrew Bryant (5704967), Terry Aspray (6194804), Luke Vale (3435356), Elaine McColl (533649), Suzanne Moffatt (16467), Sarah Lawson (6194801), Melanie Steer (6194798), Eugene M. G. Milne (2215138)   +11 more
core   +1 more source

Intensive care unit mortality and cost-effectiveness associated with intensivist staffing: a Japanese nationwide observational study

Journal of Intensive Care, 2023
Background Japan has four types of intensive care units (ICUs) that are divided into two categories according to the management fee charged per day: ICU management fees 1 and 2 (ICU1/2) (equivalent to high-intensity staffing) and 3 and 4 (ICU3/4 ...
Saori Ikumi, Takuya Shiga, Takuya Ueda, Eichi Takaya, Yudai Iwasaki, Yu Kaiho, Kunio Tarasawa, Kiyohide Fushimi, Yukiko Ito, Kenji Fujimori, Masanori Yamauchi   +10 more
doaj   +1 more source